Prot# M12-999: Open-label, Single Arm, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered with Ribavirin (RBV) in Adult Liver Transplant Recipients with Genotype

Project: Research project

Project Details

StatusFinished
Effective start/end date4/15/134/15/19

Funding

  • AbbVie Inc. (Prot # M12-999)